Sergio Traversa - Sep 9, 2024 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Executive Officer, Director
Signature
/s/ Sergio Traversa
Stock symbol
RLMD
Transactions as of
Sep 9, 2024
Transactions value $
$395,115
Form type
4
Date filed
9/11/2024, 05:47 PM
Previous filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $151K +55.6K +22.78% $2.71 300K Sep 9, 2024 Direct F1, F2
transaction RLMD Common Stock Purchase $90.8K +33K +11.02% $2.75 333K Sep 10, 2024 Direct F1, F3
transaction RLMD Common Stock Purchase $154K +51.4K +15.46% $2.99 384K Sep 11, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2 Purchase prices range from $2.51 to $2.85 per share, inclusive.
F3 Purchase prices range from $2.73 to $2.80 per share, inclusive.
F4 Purchase prices range from $2.84 to $3.05 per share, inclusive.